Vaniprevir

DB11929InvestigationalSmall molecule

Vaniprevir has been used in trials studying the treatment and diagnostic of Hepatitis C, Chronic Hepatitis C, Hepatitis C, Chronic, Chronic Hepatitis C Infection, and Chronic Genotype 1 Hepatitis C...

Formula / weight: C₃₈H₅₅N₅O₉S · 757.936 g/mol (avg)
Code names: MK-7009

Resolves to

Compound

UNIICV3X74AO1HCAS923590-37-8PubChem24765256

Clinical / RWD

PharmGKBPA166128169

Structure

InChIKeyKUQWGLQLLVFLSM-ONAXAZCASA-NSMILES

[H][C@]1(C[C@@H]2CN1C(=O)[C@@H](NC(=O)OCC(C)(C)CCCCC1=C3CN(CC3=CC=C1)C(=O)O2)C(C)(C)C)C(=O)N[C@@]1(C[C@H]1CC)C(=O)NS(=O)(=O)C1CC1

Targets

P03366gag-pol

What you can answer from here — as of August 30, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

7Clinical trialsPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with Vaniprevir, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account